WO2002094282A3 - Zusammensetzungen mit methylprednisolonderivaten mit therapeutischer wirkung - Google Patents

Zusammensetzungen mit methylprednisolonderivaten mit therapeutischer wirkung Download PDF

Info

Publication number
WO2002094282A3
WO2002094282A3 PCT/EP2002/003631 EP0203631W WO02094282A3 WO 2002094282 A3 WO2002094282 A3 WO 2002094282A3 EP 0203631 W EP0203631 W EP 0203631W WO 02094282 A3 WO02094282 A3 WO 02094282A3
Authority
WO
WIPO (PCT)
Prior art keywords
compositions
therapeutic effect
derivatives
methylprednisolone
methylprednisolone derivatives
Prior art date
Application number
PCT/EP2002/003631
Other languages
English (en)
French (fr)
Other versions
WO2002094282A2 (de
Inventor
Bernhard Tewes
Uwe Marx
Ernie H Purwaningsih
Martin Hagen
Original Assignee
Bernina Biosystems Gmbh
Bernhard Tewes
Uwe Marx
Ernie H Purwaningsih
Martin Hagen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bernina Biosystems Gmbh, Bernhard Tewes, Uwe Marx, Ernie H Purwaningsih, Martin Hagen filed Critical Bernina Biosystems Gmbh
Publication of WO2002094282A2 publication Critical patent/WO2002094282A2/de
Publication of WO2002094282A3 publication Critical patent/WO2002094282A3/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Transplantation (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)

Abstract

Die Erfindung betrifft Zusammensetzungen mit Methylprednisolon (MPL)-Derivaten mit therapeutischer Wirkung. Erfindungsgemässe werden lipidlösliche Methylprednisolon-Derivate der allgemeinen Formel (I) in Zusammensetzungen eingesetzt, wobei R eine Monocarbonsäure mit einer unverzweigten Alkylkette der Länge C9 bis C19 ist. Bevorzugt ist dabei eine Verbindung mit R=Palmitoyl.
PCT/EP2002/003631 2001-03-30 2002-04-02 Zusammensetzungen mit methylprednisolonderivaten mit therapeutischer wirkung WO2002094282A2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10116197A DE10116197A1 (de) 2001-03-30 2001-03-30 Neue Methylprednisolonderivate mit therapeutischer Wirkung
DE10116197.2 2001-03-30

Publications (2)

Publication Number Publication Date
WO2002094282A2 WO2002094282A2 (de) 2002-11-28
WO2002094282A3 true WO2002094282A3 (de) 2003-09-25

Family

ID=7679971

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2002/003631 WO2002094282A2 (de) 2001-03-30 2002-04-02 Zusammensetzungen mit methylprednisolonderivaten mit therapeutischer wirkung

Country Status (2)

Country Link
DE (1) DE10116197A1 (de)
WO (1) WO2002094282A2 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10249401A1 (de) * 2002-10-23 2004-05-13 Bernina Biosystems Gmbh Liposomen formende Zusammensetzung
WO2017040702A1 (en) * 2015-08-31 2017-03-09 The Regents Of The University Of California Bipolar tetraether lipids

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4693999A (en) * 1984-07-30 1987-09-15 Aktiebolaget Draco Liposomes containing steroid esters
WO1992015286A1 (en) * 1991-02-27 1992-09-17 Nova Pharmaceutical Corporation Anti-infective and anti-inflammatory releasing systems for medical devices
US5356633A (en) * 1989-10-20 1994-10-18 Liposome Technology, Inc. Method of treatment of inflamed tissues
DE19607722A1 (de) * 1996-02-29 1997-09-04 Freisleben H J Dr Tetraetherlipide und diese enthaltende Liposomen sowie deren Verwendung

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0381286A (ja) * 1989-08-22 1991-04-05 Green Cross Corp:The ステロイド外用剤

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4693999A (en) * 1984-07-30 1987-09-15 Aktiebolaget Draco Liposomes containing steroid esters
US5356633A (en) * 1989-10-20 1994-10-18 Liposome Technology, Inc. Method of treatment of inflamed tissues
WO1992015286A1 (en) * 1991-02-27 1992-09-17 Nova Pharmaceutical Corporation Anti-infective and anti-inflammatory releasing systems for medical devices
DE19607722A1 (de) * 1996-02-29 1997-09-04 Freisleben H J Dr Tetraetherlipide und diese enthaltende Liposomen sowie deren Verwendung

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
ANTIMISIARIS S G ET AL: "Liposome-coated metal stents: An in vitro evaluation of controlled-release modality in the ureter.", JOURNAL OF ENDOUROLOGY, vol. 14, no. 9, November 2000 (2000-11-01), pages 743 - 747, XP001105854, ISSN: 0892-7790 *

Also Published As

Publication number Publication date
WO2002094282A2 (de) 2002-11-28
DE10116197A1 (de) 2002-10-17

Similar Documents

Publication Publication Date Title
IL174471A (en) A method for making quinolinone compounds and preparations containing such compounds
WO2007041167A3 (en) Process for production of delta-9-tetrahydrocannabinol
WO2005089256A3 (en) Antiangiogenic agents
ATE260255T1 (de) 5-oxo-pyrrolidine-2-carbonsäure- hydroxamidderivate
WO2002020501A3 (en) Polyarylcarboxamides useful as lipid lowering agents
DK1089724T3 (da) Cyanosubstituerede oleanolsyrederivater som NO-produktionsinhibitorer
BR0010242A (pt) Composições quìmicas que atraem artrópodes
WO2009081152A3 (en) Antimicrobial compounds
AU624526B2 (en) Benzopyran compounds, processes for their production and pharmaceutical compositions
EP1634874A4 (de) Imidazolidinderivate
WO2004080922A3 (en) Substituted vitamin d analogues and their therapeutic uses
EP1279665A3 (de) Ein Verfahren zur Herstellung von Perindopril, analogen Verbindungen dazu sowie Salzen davon unter Verwendung von 2,5-Dioxooxazolidin-Zwischenprodukten
WO2004034976A3 (en) Dihydroartemisinin and dihydroartemisitene dimers as anti-cancer nd anti-infective agents
IL150335A0 (en) Method for the preparation of citalopram
WO2009083532A3 (en) Novel method for the preparation of derivatives of dihydrotetraazapentacenes, products such as obtained, and uses thereof
WO2005063786A3 (en) Process for fluorocytidine derivatives
PL360499A1 (en) Method of manufacture of donepezyl
EP2266971A3 (de) HIV-Protease inhibierende Verbindungen
WO2002094282A3 (de) Zusammensetzungen mit methylprednisolonderivaten mit therapeutischer wirkung
DK1663122T3 (da) Mundskyllesammensætninger indeholdende N-acyl-argininalkylestersalte
EP1390343A4 (de) Neue retinoidderivate und verfahren zur herstellung dieser verbindungen, sowie eine pharmazeutische anti-krebs-zusammensetzung, die diese verbindungen enthält
NO20053712L (no) Fremgangsmate for fremstilling av substituerte imidazolderivater og mellomprodukter anvendt i fremgangsmaten
TR200000196T2 (tr) Avermektin bileşiklerinin üretimi.
AU2002218422A1 (en) New desloratadine salts, process for their synthesis and pharmaceutical compositions thereof
BR0102655A (pt) Processo para preparação de alquil- ou ariloxiacetaldeìdos

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP